Role of free radical reactions in ischemic brain injury

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Free radical reactions figure prominently in ischemic brain injury by inducing lipid peroxidation and damage to DNA and proteins. Several research areas have attracted recent attention, including the pathophysiological roles of nitric oxide (NO) radical and the peroxynitrite anion, formed by the reaction of NO with superoxide; the vulnerability of mitochondria to oxidative injury; and the relevance of both vascular sites (e.g., endothelial injury, neutrophil activation and secretion of radical species) and parenchymal sites of radical-mediated injury. A variety of biomarkers have been validated for the detection of radical products and radical-mediated injury to lipids, DNA and proteins. Pharmacological advances in antioxidant therapy include the development of novel nitrone-based spin trap agents with neuroprotective properties. Human serum albumin in moderate-to-high doses has been shown to be strikingly neuroprotective in brain ischemia, and its effects may be mediated by antioxidant mechanisms. The use of transgenic and knockout mutant mice has proved enormously useful in elucidating oxidant injury mechanisms in cerebral ischemia.

Original languageEnglish
Pages (from-to)81-88
Number of pages8
JournalDrug News and Perspectives
Volume14
Issue number2
StatePublished - May 24 2001

Fingerprint

Brain Injuries
Free Radicals
Wounds and Injuries
Brain Ischemia
Nitric Oxide
Antioxidants
Neutrophil Activation
Peroxynitrous Acid
Neuroprotective Agents
Oxidants
Knockout Mice
Serum Albumin
Superoxides
Lipid Peroxidation
DNA Damage
Anions
Blood Vessels
Mitochondria
Proteins
Biomarkers

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of free radical reactions in ischemic brain injury. / Ginsberg, Myron.

In: Drug News and Perspectives, Vol. 14, No. 2, 24.05.2001, p. 81-88.

Research output: Contribution to journalArticle

@article{241b9b6c3fb340cab6a67a44e25f4af3,
title = "Role of free radical reactions in ischemic brain injury",
abstract = "Free radical reactions figure prominently in ischemic brain injury by inducing lipid peroxidation and damage to DNA and proteins. Several research areas have attracted recent attention, including the pathophysiological roles of nitric oxide (NO) radical and the peroxynitrite anion, formed by the reaction of NO with superoxide; the vulnerability of mitochondria to oxidative injury; and the relevance of both vascular sites (e.g., endothelial injury, neutrophil activation and secretion of radical species) and parenchymal sites of radical-mediated injury. A variety of biomarkers have been validated for the detection of radical products and radical-mediated injury to lipids, DNA and proteins. Pharmacological advances in antioxidant therapy include the development of novel nitrone-based spin trap agents with neuroprotective properties. Human serum albumin in moderate-to-high doses has been shown to be strikingly neuroprotective in brain ischemia, and its effects may be mediated by antioxidant mechanisms. The use of transgenic and knockout mutant mice has proved enormously useful in elucidating oxidant injury mechanisms in cerebral ischemia.",
author = "Myron Ginsberg",
year = "2001",
month = "5",
day = "24",
language = "English",
volume = "14",
pages = "81--88",
journal = "Drug News and Perspectives",
issn = "0214-0934",
publisher = "Prous Science",
number = "2",

}

TY - JOUR

T1 - Role of free radical reactions in ischemic brain injury

AU - Ginsberg, Myron

PY - 2001/5/24

Y1 - 2001/5/24

N2 - Free radical reactions figure prominently in ischemic brain injury by inducing lipid peroxidation and damage to DNA and proteins. Several research areas have attracted recent attention, including the pathophysiological roles of nitric oxide (NO) radical and the peroxynitrite anion, formed by the reaction of NO with superoxide; the vulnerability of mitochondria to oxidative injury; and the relevance of both vascular sites (e.g., endothelial injury, neutrophil activation and secretion of radical species) and parenchymal sites of radical-mediated injury. A variety of biomarkers have been validated for the detection of radical products and radical-mediated injury to lipids, DNA and proteins. Pharmacological advances in antioxidant therapy include the development of novel nitrone-based spin trap agents with neuroprotective properties. Human serum albumin in moderate-to-high doses has been shown to be strikingly neuroprotective in brain ischemia, and its effects may be mediated by antioxidant mechanisms. The use of transgenic and knockout mutant mice has proved enormously useful in elucidating oxidant injury mechanisms in cerebral ischemia.

AB - Free radical reactions figure prominently in ischemic brain injury by inducing lipid peroxidation and damage to DNA and proteins. Several research areas have attracted recent attention, including the pathophysiological roles of nitric oxide (NO) radical and the peroxynitrite anion, formed by the reaction of NO with superoxide; the vulnerability of mitochondria to oxidative injury; and the relevance of both vascular sites (e.g., endothelial injury, neutrophil activation and secretion of radical species) and parenchymal sites of radical-mediated injury. A variety of biomarkers have been validated for the detection of radical products and radical-mediated injury to lipids, DNA and proteins. Pharmacological advances in antioxidant therapy include the development of novel nitrone-based spin trap agents with neuroprotective properties. Human serum albumin in moderate-to-high doses has been shown to be strikingly neuroprotective in brain ischemia, and its effects may be mediated by antioxidant mechanisms. The use of transgenic and knockout mutant mice has proved enormously useful in elucidating oxidant injury mechanisms in cerebral ischemia.

UR - http://www.scopus.com/inward/record.url?scp=0035033252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035033252&partnerID=8YFLogxK

M3 - Article

C2 - 12819799

AN - SCOPUS:0035033252

VL - 14

SP - 81

EP - 88

JO - Drug News and Perspectives

JF - Drug News and Perspectives

SN - 0214-0934

IS - 2

ER -